SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+16.38%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$478M
AUM Growth
+$478M
(+4.7%)
Cap. Flow
-$13.6M
Cap. Flow
% of AUM
-2.84%
Top 10 Holdings %
Top 10 Hldgs %
39.23%
Holding
111
New
20
Increased
19
Reduced
33
Closed
21
Top Buys
| 1 |
Centene
CNC
|
$13.9M |
| 2 |
Cigna
CI
|
$10.8M |
| 3 |
Merck
MRK
|
$9.64M |
| 4 |
Icon
ICLR
|
$9.33M |
| 5 |
GSK
GSK
|
$9.19M |
Top Sells
| 1 |
AstraZeneca
AZN
|
$13.1M |
| 2 |
Cencora
COR
|
$12.5M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$12.3M |
| 4 |
Sanofi
SNY
|
$10.7M |
| 5 |
Amgen
AMGN
|
$9.2M |
Sector Composition
| 1 | Healthcare | 90.08% |
| 2 | Consumer Staples | 1.38% |
| 3 | Technology | 0.69% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Curis
CRIS
$20.9M
| $49.6M | 10.07% | 4,381,668 -374,770 | -8% | -$4.24M |
|
|
2
Cigna
CI
$80.3B
| $25.9M | 5.25% | 106,965 +44,700 | +72% | +$10.8M |
|
3
Cardinal Health
CAH
$35.5B
| $16.7M | 3.39% | 274,917 +119,700 | +77% | +$7.27M |
|
4
SPDR Gold Trust
GLD
$107B
| $15.5M | 3.15% | 97,009 -5,500 | -5% | -$880K |
|
|
SOLY
5
DELISTED
Soliton, Inc.
SOLY
| $14.5M | 2.94% | 824,803 -37,602 | -4% | -$661K |
|
|
6
Centene
CNC
$14.3B
| $13.9M | 2.82% | +217,500 | New | +$13.9M |
|
7
HCA Healthcare
HCA
$94.5B
| $13.8M | 2.8% | 73,173 -7,572 | -9% | -$1.43M |
|
|
SPRB
8
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $13.5M | 2.74% | 812,884 +176,231 | +28% | +$2.93M |
|
9
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $12.4M | 2.51% | 847,862 -16,194 | -2% | -$237K |
|
|
HRC
10
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $11.9M | 2.41% | 107,647 -15,551 | -13% | -$1.72M |
|
|
11
Merck
MRK
$210B
| $9.64M | 1.96% | +125,000 | New | +$9.64M |
|
|
ALBO
12
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $9.46M | 1.92% | 268,346 -85,864 | -24% | -$3.03M |
|
13
United Therapeutics
UTHR
$13.8B
| $9.37M | 1.9% | 56,044 +17,310 | +45% | +$2.9M |
|
|
14
Icon
ICLR
$13.8B
| $9.33M | 1.89% | +47,500 | New | +$9.33M |
|
|
15
GSK
GSK
$79.9B
| $9.19M | 1.87% | +257,500 | New | +$9.19M |
|
16
AMN Healthcare
AMN
$796M
| $9.13M | 1.85% | 123,898 -6,700 | -5% | -$494K |
|
17
Universal Health Services
UHS
$11.6B
| $9.09M | 1.84% | 68,135 -12,708 | -16% | -$1.7M |
|
18
ESSA Pharma
EPIX
$11.4M
| $9.08M | 1.84% | 312,711 -120,312 | -28% | -$3.49M |
|
19
Mirum Pharmaceuticals
MIRM
$3.71B
| $8.66M | 1.76% | 437,138 -57,605 | -12% | -$1.14M |
|
|
BLRX
20
BioLineRX
BLRX
$16.2M
| $7.65M | 1.55% | +2,741,776 | New | +$7.65M |
|
21
McKesson
MCK
$85.4B
| $7.59M | 1.54% | 38,893 -8,569 | -18% | -$1.67M |
|
22
X4 Pharmaceuticals
XFOR
$84.2M
| $6.93M | 1.41% | +804,597 | New | +$6.93M |
|
23
Herbalife
HLF
$1.01B
| $6.6M | 1.34% | 148,719 +71,059 | +92% | +$3.15M |
|
|
RCOR
24
DELISTED
Renovacor, Inc.
RCOR
| $6.41M | 1.3% | +600,000 | New | +$6.41M |
|
25
Teva Pharmaceuticals
TEVA
$21.1B
| $6.23M | 1.26% | 539,947 -150,439 | -22% | -$1.74M |
|